Filter Results:
(5,102)
Show Results For
- All HBS Web
(5,102)
- People (18)
- News (1,649)
- Research (2,742)
- Events (5)
- Multimedia (111)
- Faculty Publications (1,756)
Show Results For
- All HBS Web
(5,102)
- People (18)
- News (1,649)
- Research (2,742)
- Events (5)
- Multimedia (111)
- Faculty Publications (1,756)
- February 2018
- Article
Development and Feasibility of Bundled Payments for the Multidisciplinary Treatment of Head and Neck Cancer: A Pilot Program
By: Tracy Spinks, Alexis Guzman, Beth M. Beadle, Seohyun Lee, Ron Walters, Jim Incalcaterra, Ehab Hanna, Amy Hessel, Randal Weber, Sandra Denney, Lee Newcomer and Thomas W. Feeley
Purpose:
Despite growing interest in bundled payments to reduce the costs of care, this payment method remains largely untested in cancer. This 3-year pilot tested the feasibility of a 1-year bundled payment for the multidisciplinary treatment of head and neck... View Details
Spinks, Tracy, Alexis Guzman, Beth M. Beadle, Seohyun Lee, Ron Walters, Jim Incalcaterra, Ehab Hanna, Amy Hessel, Randal Weber, Sandra Denney, Lee Newcomer, and Thomas W. Feeley. "Development and Feasibility of Bundled Payments for the Multidisciplinary Treatment of Head and Neck Cancer: A Pilot Program." Journal of Oncology Practice 14, no. 2 (February 2018): e103–e121.
- April 2006
- Case
Nutricia Middle East: Measuring Sales Force Effectiveness
Nutricia's Middle East and African region is transitioning from a trading to a customer focus. CEO Ernest Vandenbussche must decide how to market infant milk formula most effectively in a region where the information environment is much less rich than in other... View Details
Keywords: Management Teams; Salesforce Management; Customer Relationship Management; Emerging Markets; Nutrition; Performance Effectiveness; Business Strategy; Commercialization; Health Industry; Middle East; Africa
Martinez-Jerez, Francisco de Asis, and Rachel Sha. "Nutricia Middle East: Measuring Sales Force Effectiveness." Harvard Business School Case 106-063, April 2006.
- January 2018 (Revised January 2019)
- Case
ZappRx
By: Jeffrey J. Bussgang and Olivia Hull
In October 2015, ZappRx founder Zoe Barry is deciding between two business models for her health technology start-up. Her product, a software application that aims to expedite the prescription fulfillment process for patients with rare diseases, has attracted interest... View Details
- Web
Podcasts - Managing the Future of Work
Hayden Brown on bridging volatility with contingency "Freelance by choice" can sound like a rationalization—or putting on a brave face—but has the contract labor market improved for white-collar workers, as more, particularly younger... View Details
- 25 Jun 2020
- Blog Post
Harvard Business School Class of 2021 Student Profiles
Health Care Club, Co-President, PRIDE Club, Soccer Club, Tech Club, Management Consulting Club Christina Byrd “While working on cross-functional and strategic initiatives at Uber,” says Christina, “I... View Details
- 08 Oct 2013
- First Look
First Look: October 8
valuable information. Companies need to invest as much in learning from their start-ups as they do in making and overseeing deals. Publisher's link: http://hbr.org/2013/10/corporate-venturing/ar/1 August... View Details
Keywords: Sean Silverthorne
- 07 Sep 2011
- First Look
First Look: Sept. 7
Crisis in Health Care Authors:Robert S. Kaplan and Michael E. Porter Publication:Harvard Business Review 89, no. 9 (September 2011) Abstract Existing View Details
Keywords: Sean Silverthorne
- December 2006 (Revised August 2008)
- Case
Pervasis Therapeutics, Inc.
By: Robert F. Higgins and Virginia Fuller
In May 2005, Steve Bollinger was about to become president and chief operating officer of Pervasis Therapeutics, a small cell therapy start-up in Cambridge, Mass. If proven successful, Pervasis' product, Vascugel, could change the way vascular disease is treated and... View Details
Keywords: Business Startups; Venture Capital; Financial Strategy; Governing Rules, Regulations, and Reforms; Health Care and Treatment; Health Testing and Trials; Health Industry; Cambridge
Higgins, Robert F., and Virginia Fuller. "Pervasis Therapeutics, Inc." Harvard Business School Case 807-026, December 2006. (Revised August 2008.)
- August 2018
- Article
The Effect of Graphic Warnings on Sugary-Drink Purchasing
By: Grant Donnelly, Laura Y. Zatz, Daniel Svirsky and Leslie John
Governments have proposed text warning labels to decrease consumption of sugary drinks – a contributor to chronic diseases like diabetes. However, they may be less effective than more evocative, graphic warning labels. We field-tested the effectiveness of graphic... View Details
Keywords: Policy Making; Preferences; Food; Health; Policy; Information; Labels; Consumer Behavior; Decision Making; Performance Effectiveness
Donnelly, Grant, Laura Y. Zatz, Daniel Svirsky, and Leslie John. "The Effect of Graphic Warnings on Sugary-Drink Purchasing." Psychological Science 29, no. 8 (August 2018): 1321–1333.
- February 2024
- Teaching Note
AB InBev: Brewing Up Forecasts during COVID-19
By: Mark Egan and C. Fritz Foley
Teaching Note for HBS Case No. 224-020. In July 2021, the CEO of AB InBev's European operations and his team strategized to position the company for success post-pandemic. As the world's largest beer company, boasting over 500 brands, revenue of $46 billion, and a... View Details
- 01 Dec 2023
- News
Wide Horizon
There were three critical events that led John Rodakis (MBA 1997) to form the nonprofit N of One in 2014 and ultimately dedicate his life to surfacing breakthrough autism research. The first occurred on Thanksgiving of 2012. He had driven about four hours with his wife... View Details
Keywords: Dan Morrell; Photos by Sarah Wilson
- 31 Jan 2014
- Working Paper Summaries
The Diseconomies of Queue Pooling: An Empirical Investigation of Emergency Department Length of Stay
- 25 Mar 2021
- Blog Post
Meet the Student Academic Services Support Team at HBS!
resources, issues of safety, respect, and inclusion, as well as health management and disability services. Four staff members have mental health licensure in the state of... View Details
- 26 Feb 2019
- First Look
New Research and Ideas, February 26, 2019
https://www.hbs.edu/faculty/Pages/item.aspx?num=55694 forthcoming Journal of Monetary Economics U.S. Monetary Policy and Emerging Market Credit Cycles By: Bräuning, Falk, and Victoria Ivashina Abstract— Foreign banks’ lending to firms... View Details
Keywords: Dina Gerdeman
- 05 Mar 2013
- First Look
First Look: March 5
abstract available. Purchase this case:http://hbr.org/search/213051-PDF-ENG Kirkpatrick Corporation Hawkins, David F. Harvard Business School Case 113-070 No abstract available. Purchase this case:http://hbr.org/search/113070-PDF-ENG Social Media View Details
Keywords: Sean Silverthorne
- February 2022
- Case
Leading The UK Vaccine Task Force
By: Amy C. Edmondson and Claudia Pienica
This case describes the first six months of the UK Vaccine Taskforce, under the leadership of Kate Bingham. With a career spent in the private sector as a biotech investor, Bingham’s appointment within the government was considered unusual. The overarching brief given... View Details
Keywords: COVID-19; Vaccine; Government; Health Pandemics; Health Care and Treatment; Science; Innovation and Invention; Groups and Teams; Leadership; Decision Making; Government and Politics; Health; Innovation and Management; Governance; Change; Government Administration; Health Industry; Health Industry; Health Industry; Europe; United Kingdom
Edmondson, Amy C., and Claudia Pienica. "Leading The UK Vaccine Task Force." Harvard Business School Case 622-079, February 2022.
- Web
Program Requirements - Doctoral
developed for understanding—health care organizations. Coursework Health Policy Core Seminar (Health Policy 2000) Microeconomic Theory (Econ 2020a/b; HKS API 101Z/102Z; or HKS API 109/110; Econ 1460 may be... View Details
- January 2021 (Revised June 2021)
- Case
Hester Pharmaceuticals (A): A Pricing Dilemma
By: Dante Roscini and John Masko
In August 2019, the leadership of Hester Pharmaceuticals (Hester) had a problem. Italy promised to be a key market for their new breakthrough oncology drug Akrozumab, but for almost two years, its single-payer healthcare system had been unable to agree with Hester on a... View Details
Keywords: Macroeconomics; Trade; Price; Global Range; Global Strategy; Globalized Markets and Industries; Health Care and Treatment; Patents; Monopoly; Negotiation; Business and Government Relations; Risk and Uncertainty; Human Needs; Business Strategy; Commercialization; Pharmaceutical Industry; Italy
Roscini, Dante, and John Masko. "Hester Pharmaceuticals (A): A Pricing Dilemma." Harvard Business School Case 721-001, January 2021. (Revised June 2021.)
- 18 Jul 2023
- Research & Ideas
Will Global Demand for Oil Peak This Decade?
Is the globe’s thirst for oil finally topping out? A major international energy watcher says yes, predicting last month that demand for global oil for transport will peak around 2026, plateau for all uses by 2028, and possibly hit a zenith by the end of the decade.... View Details
- March 2015 (Revised December 2016)
- Case
Philips Healthcare Latin America
By: Sunil Gupta
On a beautiful sunny afternoon in October 2013, Daniel Mazon (GMP 15), decided to take some time out of his busy schedule of the General Management Program (GMP) at the Harvard Business School to reflect on his company's situation. Mazon was the Vice President and... View Details
Keywords: Healthcare; Latin America; Organizational Structure; Salesforce Management; Health Care and Treatment; Health Industry; Health Industry; Latin America
Gupta, Sunil. "Philips Healthcare Latin America." Harvard Business School Case 515-097, March 2015. (Revised December 2016.)